Manufacturing
Our facility is equipped with 3 lines of 2,500L bioreactors, as well as, a combination of single-use and multi-use systems to enable manufacturing of all phases from preclinical to commercial.
We possess downstream equipment that can handle cell culture up to 2,500L capacity to enable manufacturing of all phases from preclinical to commercial. The combination of single-use and multi-use systems allows the manufacturing of various different types of recombinant protein drugs.
Aseptic Filling
To prevent cross-contamination between different products, our facilities are equipped with a single-use system for all flow paths that come in contact with the product during the filling process. Additionally, we implemented active RABS (Restricted Access Barrier System) to safeguard against the inflow of external contaminants during this process.
Flexibility
Each year, we are producing more than 100-200 batches of domestic and foreign clinical and commercial medicines. With our rich experience, we can produce products with various properties that are packaged into vials or syringes. Depending on the purpose of use, the manufacturing process can be flexibly configured from small-scale clinical drug production to large-scale commercial production.
Our DP (Drug Product) manufacturing area consists of a vial filling line, a pre-filled syringe filling line, and a secondary packaging line such as blister and carton packaging.
